Table 4 Results of multiple linear regressions of associated factors with fracture episodes during treatment conducted by Enter method. R Square: 0.914
variables | Std.Error | Beta | p-value |
|---|---|---|---|
age | 0.197 | 1.314 | 0.003 |
gender | 0.572 | -0.349 | 0.015 |
BMI percentile | 0.010 | -0.075 | 0.548 |
Puberty | 1.128 | 0.850 | 0.005 |
Physical activity | 0.683 | 0.113 | 0.402 |
Sun exposure | 0.760 | -0.549 | 0.006 |
Vitamin D | 0.020 | -0.108 | 0.421 |
Intra uterine fracture | 0.837 | -0.266 | 0.053 |
Pamidronate therapy initiation time | 0.249 | -2.462 | 0.000 |
Number of Pamidronate injection | 0.058 | -0.878 | 0.002 |
Total time of Pamidronate therapy | 0.264 | -0.603 | 0.100 |
Lumbar BMAD | 14.062 | -0.075 | 0.511 |